EUVIMED · CrossrefZeitschrift
Nature Medicine
ISSN 1078-8956 · Springer Science and Business Media LLC
Neueste Artikel
Gut and urogenital microbiomes influence menopausal hormone therapy outcomes
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Lessons from recent investigator-initiated trials of gene-editing therapies in China
Next-generation KRAS G12C inhibitor improves survival in lung cancer
Blood-based RNA biomarker for the early detection of ovarian cancer
A novel candidate biomarker for detecting premalignant and early ovarian cancer
Author Correction: Innate lymphoid cells in the initiation, regulation and resolution of inflammation
Deep learning-based gait analysis predicts multisystem health phenotypes
An ulcerative colitis taxonomy defined by individual patient-reported response trajectories
Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity: a randomized controlled trial
Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial
Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial
A gait foundation model for prediction of multisystem health phenotypes from 3D skeletal motion
Opposing microbiome-mediated axes link modifiable lifestyles to health and chronic diseases
Digital readiness for cardiovascular care in high-burden US communities with cardiology workforce constraints
Perioperative ivonescimab with or without chemotherapy in resectable non-small cell lung cancer: a phase 2 trial
A tumor transcriptomic atlas across eight decades of life reveals distinct features of early-onset colorectal cancer
Global temperature-related mortality associated with El-Nino Southern Oscillation
A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial
Heterogeneity of microbiome responses to menopausal hormone therapy among perimenopausal women
Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials
Author Correction: In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy
Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial
Global, regional and national burden of cervical cancer in 1990–2023 with forecasts to 2050: a Global Burden of Disease study
Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials
Climate change threatens malaria elimination in the Asia Pacific
A small-molecule TREM2 agonist for Alzheimer’s disease
Applying digital twins to prevent preterm births
A clinical multimodal vision language foundation model with fine-grain explainability
Jahrgänge
2026 · 6172025 · 7512024 · 7252023 · 6182022 · 5632021 · 5062020 · 4952019 · 4372018 · 3612017 · 2612016 · 2912015 · 3062014 · 4172013 · 5112012 · 5822011 · 6162010 · 5702009 · 4682008 · 4332007 · 4582006 · 4942005 · 4652004 · 5222003 · 5112002 · 5042001 · 5112000 · 5531999 · 5761998 · 6081997 · 5791996 · 6191995 · 603
EUVIMED